34%; p<0.001).Incidence of VA-LRTI was significantly lower among immunocompromised patients, but it was associated with a significantly higher mortality rate. Multidrug-resistant pathogens were more frequently found in immunocompromised patients with VA-LRTI.
No takes yet. Share an insight, caveat, or question.
Moreau et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: